Double Swords 双剑论股
CTOS MRGC SDS CCK LAYHONG ABLEGLOB SWIFT PHARMA FLBHD 筹码峰分析. 会员问股福利. 盘后技术分析. 04082022.
Double Swords 双剑论股
Publish date: Thu, 04 Aug 2022, 07:38 PM
Double Swords 双剑论股
0 4,078
Double Swords 双剑论股 https://www.youtube.com/channel/UCfBCbkqZM8xLGjvN-ucIbeQ
双剑合璧KLSE吹水站
https://t.me/joinchat/wsTteKWMlw5kN2Y1
基本面技术面双剑合璧
https://www.facebook.com/groups/203715566878990/
Old Friends Investing
http://oldfriendsinvesting.blogspot.com/
Tradingview Volume Profile indicators 筹码峰
https://www.tradingview.com/gopro/?share_your_love=wongpingloong
双剑合璧KLSE吹水站
https://t.me/joinchat/wsTteKWMlw5kN2Y1
基本面技术面双剑合璧
https://www.facebook.com/groups/203715566878990/
Old Friends Investing
http://oldfriendsinvesting.blogspot.com/
Tradingview Volume Profile indicators 筹码峰
https://www.tradingview.com/gopro/?share_your_love=wongpingloong
More articles on Double Swords 双剑论股
MAYBANK MALAYAN BANKING 顶部横盘多时，是否暗示久盘必跌？[CC 中英文字幕 ENG SUB].
Created by Double Swords 双剑论股 | Apr 16, 2024
大马手套股 TOPGLOV HARTA KOSSAN SUPERMX 净卖空仓位 NET SHORT POSITIONS. [CC 中英文字幕 ENG SUB].
Created by Double Swords 双剑论股 | Apr 16, 2024
BJFOOD BERJAYA FOOD 私有化传闻推动股价上涨！筹码主力线怎么看？[CC 中英文字幕 ENG SUB].
Created by Double Swords 双剑论股 | Apr 14, 2024
HARTA HARTALEGA 涨势乏力，短期业绩黯淡, 股价难突破3.00 阻力! [CC 中英文字幕 ENG SUB]
Created by Double Swords 双剑论股 | Apr 09, 2024
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
Apps
Top Articles
2
3
4
Koon Yew Yin's Blog
5
Good Articles to Share
Slower US Fed pivot weakens rate-cut bets across emerging Asia
6
7
Good Articles to Share
8
Good Articles to Share
Bank of America CEO talks earnings, consumer spending, and inflation
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
MQ Trading Signals
Stock
Time
Signal
Duration
Stock
Time
Signal
Duration
TWL HOLDINGS BERHAD - REDEEMABLE CONVERTIBLE UNSECURED LOAN STOCKS 2023/2028
2024-04-19 16:55:00
ADX
5 Mins
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
